These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

224 related items for PubMed ID: 11888633

  • 1. Fusidic acid resistance in Staphylococcus aureus isolates.
    Brown EM, Thomas P.
    Lancet; 2002 Mar 02; 359(9308):803. PubMed ID: 11888633
    [No Abstract] [Full Text] [Related]

  • 2. Fusidic acid resistance in community isolates of methicillin-susceptible Staphylococcus aureus and fusidic acid prescribing.
    Mason BW, Howard AJ, Magee JT.
    J Antimicrob Chemother; 2003 Apr 02; 51(4):1033-6. PubMed ID: 12654748
    [Abstract] [Full Text] [Related]

  • 3. Fusidic acid resistance in community isolates of methicillin susceptible Staphylococcus aureus and the use of topical fusidic acid: a retrospective case-control study.
    Mason BW, Howard AJ.
    Int J Antimicrob Agents; 2004 Mar 02; 23(3):300-3. PubMed ID: 15164973
    [Abstract] [Full Text] [Related]

  • 4. Oral fusidic acid fails to eradicate methicillin-resistant Staphylococcus aureus colonization and results in emergence of fusidic acid-resistant strains.
    Chang SC, Hsieh SM, Chen ML, Sheng WH, Chen YC.
    Diagn Microbiol Infect Dis; 2000 Feb 02; 36(2):131-6. PubMed ID: 10705056
    [Abstract] [Full Text] [Related]

  • 5. Dumb and dumber--the potential waste of a useful antistaphylococcal agent: emerging fusidic acid resistance in Staphylococcus aureus.
    Howden BP, Grayson ML.
    Clin Infect Dis; 2006 Feb 01; 42(3):394-400. PubMed ID: 16392088
    [Abstract] [Full Text] [Related]

  • 6. High usage of topical fusidic acid and rapid clonal expansion of fusidic acid-resistant Staphylococcus aureus: a cautionary tale.
    Williamson DA, Monecke S, Heffernan H, Ritchie SR, Roberts SA, Upton A, Thomas MG, Fraser JD.
    Clin Infect Dis; 2014 Nov 15; 59(10):1451-4. PubMed ID: 25139961
    [Abstract] [Full Text] [Related]

  • 7. Susceptibility of Staphylococcus aureus to fusidic acid: Canadian data.
    Rennie RP.
    J Cutan Med Surg; 2006 Nov 15; 10(6):277-80. PubMed ID: 17241597
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. In vitro susceptibility of Staphylococcus aureus and coagulase-negative Staphylococcus strains to fusidic acid.
    Tünger O, Arisoy A, Kurutepe S, Akçali S, Ozbakkaloğlu B.
    Int J Antimicrob Agents; 2001 Nov 15; 18(5):445-7. PubMed ID: 11711260
    [No Abstract] [Full Text] [Related]

  • 10. [Increase in rate of resistance to fusidic acid among Staphylococcus aureus isolates from patients admitted with atopic dermatitis].
    Peeters KA, Mascini EM, Blok HE, Sanders CJ.
    Ned Tijdschr Geneeskd; 2002 Nov 02; 146(44):2100-1. PubMed ID: 12448968
    [Abstract] [Full Text] [Related]

  • 11. Topical Fucidin.
    Dealler S, Fraser AK.
    J R Coll Gen Pract; 1986 Mar 02; 36(284):136. PubMed ID: 3712354
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Activity of fusidic acid against extracellular and intracellular Staphylococcus aureus: influence of pH and comparison with linezolid and clindamycin.
    Lemaire S, Van Bambeke F, Pierard D, Appelbaum PC, Tulkens PM.
    Clin Infect Dis; 2011 Jun 02; 52 Suppl 7():S493-503. PubMed ID: 21546626
    [Abstract] [Full Text] [Related]

  • 14. Multiple combination bactericidal testing of staphylococcal biofilms from implant-associated infections.
    Saginur R, Stdenis M, Ferris W, Aaron SD, Chan F, Lee C, Ramotar K.
    Antimicrob Agents Chemother; 2006 Jan 02; 50(1):55-61. PubMed ID: 16377667
    [Abstract] [Full Text] [Related]

  • 15. Efforts to support the development of fusidic acid in the United States.
    Fernandes P, Pereira D.
    Clin Infect Dis; 2011 Jun 02; 52 Suppl 7():S542-6. PubMed ID: 21546632
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Survey, characterization and susceptibility to fusidic acid of Staphylococcus aureus in the Carmarthen area.
    El-Zimaity D, Kearns AM, Dawson SJ, Price S, Harrison GA.
    J Antimicrob Chemother; 2004 Aug 02; 54(2):441-6. PubMed ID: 15269197
    [Abstract] [Full Text] [Related]

  • 18. A fusidic acid-resistant epidemic strain of Staphylococcus aureus carries the fusB determinant, whereas fusA mutations are prevalent in other resistant isolates.
    O'Neill AJ, Larsen AR, Henriksen AS, Chopra I.
    Antimicrob Agents Chemother; 2004 Sep 02; 48(9):3594-7. PubMed ID: 15328136
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.